Maxim Zaslavsky is a founder and CEO with 15 years of experience building machine learning and sequencing-based diagnostics to bring personalized medicine to autoimmune patients. He spun out Stanford PhD and postdoc research to commercialize a novel approach that reads the immune system’s “records,” with work published in Science and featured in major outlets like The New York Times and The Wall Street Journal. Prior roles span product leadership at Butterfly Network—where he managed mobile ultrasound software—and data-driven research and engineering positions at Icahn Mount Sinai, NYT, and Nest, combining product, ML, and biomedical expertise. Known for translating deep academic research into clinic-ready products, he leads a cross-disciplinary team focused on deploying AI-powered blood tests for RA, IBD, and MS. An early technologist who built widely used campus apps at Princeton, he blends hands-on engineering with scientific rigor and a knack for communicating complex biology to clinicians and investors.
15 years of coding experience
5 years of employment as a software developer
Doctor of Philosophy - PhD Computer Science, Doctor of Philosophy - PhD Computer Science at Stanford University
Bachelor of Science in Engineering (B.S.E) Computer Science, Bachelor of Science in Engineering (B.S.E) Computer Science at Princeton University
Contributions:48 commits, 6 PRs, 12 pushes in 1 year 2 months
searchpersonal-search
Find and Hire Top DevelopersWe’ve analyzed the programming source code of over 60 million software developers on GitHub and scored them by 50,000 skills. Sign-up on Prog,AI to search for software developers.